Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2024 Jul 5;15:1441843. doi: 10.3389/fimmu.2024.1441843

Corrigendum: Identification of m6A modification patterns and development of m6A–hypoxia prognostic signature to characterize tumor microenvironment in triple-negative breast cancer

Xi Shen 1,, Jianxin Zhong 2,, Jinlan He 1, Jiaqi Han 1, Nianyong Chen 1,*
PMCID: PMC11258394  PMID: 39034994

In the published article, there was an error in Figure 9F as published. After checking the original paper, the images of Figure 9F were mistakenly included. The corrected Figure 9 and its caption Figure 9 Nomogram and detection of MHPS gene expression. appear below.

Figure 9.

Figure 9

Nomogram and detection of MHPS gene expression. (A) Kaplan-Meier analysis of patients with high or low MHPS risk socre in METABRIC-TNBC cohort. (B) Construction of nomogram scoring system to predict patient survival at 1-, 3- and 5- years. Each clinical factor in the nomogram system corresponds to a score, and all scores are summed to obtain a total point, which can predict the survival rate of patients at 1-, 3- and 5- years. (C) Time-dependent ROC for the nomogram, MHPS, tumor size, lymph node in the METABRIC cohort (for predicting 1, 3, and 5-years OS). (D) Comparison of mRNA expression of hub genes in normal breast and TNBC cell lines. (E) Different expression of hub genes in normoxia and hypoxia cultured TNBC cells based on GSE144569 dataset. (F) IHC staining to detect protein expression of PIM2 and MKP1 in normal and tumor tissues. Scale bar:100μm.(*P< 0.05,**P< 0.01, and ***P< 0.001). ns, not significant.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES